Table: Rohto - 6-MTH group results
Nov 11 (Reuters)-
Rohto Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2021 Sep 30, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 91.02 83.00 190.00
(-8.2 pct) (+4.8 pct)
Operating 13.77 10.17 25.00
(-2.1 pct) (+8.7 pct)
Recurring 13.51 10.48 25.00
(-3.7 pct) (+4.6 pct)
Net 10.76 5.80 18.00
(-20.6 pct) (+7.5 pct)
EPS 94.30 yen 50.83 yen 157.80 yen
EPS Diluted 94.03 yen 50.68 yen
Ann Div 28.00 yen 30.00 yen
-Q2 div 15.00 yen 13.00 yen
-Q4 div 15.00 yen 15.00 yen
NOTE - Rohto Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T